131 related articles for article (PubMed ID: 38376298)
61. Assessment of the association of
Barek MA; Basher MA; Aziz MA; Hossen MS; Jahan N; Afroz N; Begum M; Jafrin S; Uddin MS; Millat MS; Hoque MM; Islam MS
Heliyon; 2023 Jul; 9(7):e17712. PubMed ID: 37483787
[TBL] [Abstract][Full Text] [Related]
62. [Development of rapid genotyping methods for single nucleotide polymorphisms of cytochrome P450 2C9 (CYP2C9) and cytochrome P450 2C19 (CYP2C19) and their clinical application in pediatric patients with epilepsy].
Yamamoto Y; Takahashi Y; Nishimura S; Ikumi Y; Mishima N; Kagawa Y
Yakugaku Zasshi; 2011; 131(5):809-15. PubMed ID: 21532277
[TBL] [Abstract][Full Text] [Related]
63. Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population.
Skadrić I; Stojković O
Int J Legal Med; 2020 Mar; 134(2):433-439. PubMed ID: 31858263
[TBL] [Abstract][Full Text] [Related]
64. Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Macedonia.
Jakovski K; Nestorovska AK; Labacevski N; Dimovski AJ
Pharmazie; 2013 Nov; 68(11):893-8. PubMed ID: 24380239
[TBL] [Abstract][Full Text] [Related]
65. Cytochrome P450 gene polymorphism and cancer.
Agundez JA
Curr Drug Metab; 2004 Jun; 5(3):211-24. PubMed ID: 15180491
[TBL] [Abstract][Full Text] [Related]
66. Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population.
Tai J; Yang M; Ni X; Yu D; Fang J; Tan W; Huang Z; Wu C; Chen X; Wang G; Zhou W; Chen X; Zhang W; Ma L; Lin D; Han D
Cancer Genet Cytogenet; 2010 Jan; 196(1):76-82. PubMed ID: 19963139
[TBL] [Abstract][Full Text] [Related]
67. Cytochrome P450 1A1, 2C9, 2C19, and 3A4 Polymorphisms Account for Interindividual Variability of Toxicological Drug Metabolism in Cynomolgus Macaques.
Uno Y; Uehara S; Murayama N; Yamazaki H
Chem Res Toxicol; 2018 Dec; 31(12):1373-1381. PubMed ID: 30412386
[TBL] [Abstract][Full Text] [Related]
68. Influence of CYP2C9 and CYP2C19 genetic polymorphisms on phenytoin-induced neurological toxicity in Indian epileptic patients.
Kesavan R; Narayan SK; Adithan C
Eur J Clin Pharmacol; 2010 Jul; 66(7):689-96. PubMed ID: 20390258
[TBL] [Abstract][Full Text] [Related]
69. Impact of single nucleotide polymorphism in chemical metabolizing genes and exposure to wood smoke on risk of cervical cancer in North-Indian women.
Satinder K; Sobti RC; Pushpinder K
Exp Oncol; 2017 Mar; 39(1):69-74. PubMed ID: 28361858
[TBL] [Abstract][Full Text] [Related]
70. Novel Cytochrome P450 2C119 Enzymes in Cynomolgus and Rhesus Macaques Metabolize Progesterone, Diclofenac, and Omeprazole.
Uno Y; Murayama N; Yamazaki H
Drug Metab Dispos; 2024 Feb; 52(3):266-273. PubMed ID: 38123944
[TBL] [Abstract][Full Text] [Related]
71. Impact of genetic polymorphisms in CYP2C9 and CYP2C19 on the pharmacokinetics of clinically used drugs.
Hirota T; Eguchi S; Ieiri I
Drug Metab Pharmacokinet; 2013; 28(1):28-37. PubMed ID: 23165865
[TBL] [Abstract][Full Text] [Related]
72. Meta-Analysis of Polymorphic Variants Conferring Genetic Risk to Cervical Cancer in Indian Women Supports CYP1A1 as an Important Associated Locus.
Sengupta D; Guha U; Mitra S; Ghosh S; Bhattacharjee S; Sengupta M
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2071-2081. PubMed ID: 30139066
[TBL] [Abstract][Full Text] [Related]
73. [Genetic polymorphism of the CYP2C subfamily].
Chiba K
Nihon Yakurigaku Zasshi; 1998 Jul; 112(1):15-21. PubMed ID: 9755458
[TBL] [Abstract][Full Text] [Related]
74. Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study.
Bravo-Villalta HV; Yamamoto K; Nakamura K; Bayá A; Okada Y; Horiuchi R
Eur J Clin Pharmacol; 2005 May; 61(3):179-84. PubMed ID: 15776277
[TBL] [Abstract][Full Text] [Related]
75. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.
Zand N; Tajik N; Moghaddam AS; Milanian I
Clin Exp Pharmacol Physiol; 2007; 34(1-2):102-5. PubMed ID: 17201743
[TBL] [Abstract][Full Text] [Related]
76. CYP1A1m1 and CYP2C9*2 and *3 polymorphism and risk to develop ARV-associated hepatotoxicity and its severity.
Singh H; Lata S; Nema V; Samani D; Ghate M; Gangakhedkar RR
APMIS; 2017 Jun; 125(6):523-535. PubMed ID: 28370504
[TBL] [Abstract][Full Text] [Related]
77. Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population.
Sukprasong R; Chuwongwattana S; Koomdee N; Jantararoungtong T; Prommas S; Jinda P; Rachanakul J; Nuntharadthanaphong N; Jongjitsook N; Puangpetch A; Sukasem C
Sci Rep; 2021 Jun; 11(1):12343. PubMed ID: 34117307
[TBL] [Abstract][Full Text] [Related]
78. Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus.
Semiz S; Dujic T; Ostanek B; Prnjavorac B; Bego T; Malenica M; Marc J; Causevic A
Bosn J Basic Med Sci; 2010 Nov; 10(4):287-91. PubMed ID: 21108610
[TBL] [Abstract][Full Text] [Related]
79. Lack of association between genetic polymorphisms of CYP3A4, CYP2C9 and CYP2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population.
Tang SW; Lv XZ; Chen R; Wu SS; Yang ZR; Chen DF; Zhan SY
Clin Exp Pharmacol Physiol; 2013 May; 40(5):326-32. PubMed ID: 23469989
[TBL] [Abstract][Full Text] [Related]
80. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]